FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2015 13F Holders as of 31 Mar 2015
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 10,608,782
- Share change
- +333,477
- Total reported value
- $51,875,000
- Price per share
- $4.89
- Number of holders
- 25
- Value change
- +$1,628,433
- Number of buys
- 14
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.5%
|
3,084,373
|
$15,514,000 | — | 31 Dec 2014 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$12,440,000 | — | 31 Dec 2014 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.3%
|
1,554,175
|
$7,818,000 | — | 31 Dec 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.2%
|
1,420,928
|
$7,147,000 | — | 31 Dec 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
692,900
|
$3,485,000 | — | 31 Dec 2014 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.24%
|
291,067
|
$1,464,000 | — | 31 Dec 2014 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
207,700
|
$1,045,000 | — | 31 Dec 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.14%
|
171,938
|
$865,000 | — | 31 Dec 2014 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.06%
|
76,494
|
$385,000 | — | 31 Dec 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
73,436
|
$369,000 | — | 31 Dec 2014 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.05%
|
59,110
|
$297,000 | — | 31 Dec 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
38,400
|
$193,000 | — | 31 Dec 2014 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.03%
|
33,275
|
$167,000 | — | 31 Dec 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,384
|
$157,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
30,796
|
$154,000 | — | 31 Dec 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.02%
|
23,926
|
$120,000 | — | 31 Dec 2014 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4,035
|
$20,000 | — | 31 Dec 2014 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,264
|
$11,000 | — | 31 Dec 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
2,248
|
$11,000 | — | 31 Dec 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$10,000 | — | 31 Dec 2014 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
770
|
$4,000 | — | 31 Dec 2014 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
700
|
$3,000 | — | 31 Dec 2014 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Dec 2014 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2015
As of 31 Mar 2015,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,608,782 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, HIGHLAND CAPITAL MANAGEMENT LP, Board of Trustees of The Leland Stanford Junior University, PRINCIPAL FINANCIAL GROUP INC, VANGUARD GROUP INC, and Alyeska Investment Group, L.P..
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
23
Q1 2015 holders
25
Holder diff
2
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.